Miltenyi Biotec

• European Commission

  HORIZON-RIA, Universal Satellite Cell-like Stem Cells for Muscle Regeneration: AI-powered Cell Engineering, Manufacturing and Precision Delivery, 101288213, €660.7k, 2026–2031, 1 Oct 2026

• European Commission

  HORIZON-TMA-MSCA-DN, Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy, 101227159, €290.3k, 2025–2029, 30 Jun 2025

Sources: cordis.europa.eu

• TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy

  Fees or honoraria, 24 Aug 2026

• More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases

  Consulting or advice, Fees or honoraria, Grants or research support, 15 Feb 2026

• Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas

  Employment, 24 Oct 2025

Sources: pubmed.ncbi.nlm.nih.gov